These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 25618410)

  • 1. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
    Eschenhagen T; Mummery C; Knollmann BC
    Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomeric cardiomyopathies: from bedside to bench and back.
    Hasenfuss G
    Cardiovasc Res; 2015 Apr; 105(4):395-6. PubMed ID: 25681397
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
    Bedada FB; Wheelwright M; Metzger JM
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
    Ross SB; Fraser ST; Semsarian C
    Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells.
    Sewanan LR; Campbell SG
    J Physiol; 2020 Jul; 598(14):2909-2922. PubMed ID: 30624779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal and in silico models for the study of sarcomeric cardiomyopathies.
    Duncker DJ; Bakkers J; Brundel BJ; Robbins J; Tardiff JC; Carrier L
    Cardiovasc Res; 2015 Apr; 105(4):439-48. PubMed ID: 25600962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
    Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
    Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
    Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic advances in sarcomeric cardiomyopathies: state of the art.
    Ho CY; Charron P; Richard P; Girolami F; Van Spaendonck-Zwarts KY; Pinto Y
    Cardiovasc Res; 2015 Apr; 105(4):397-408. PubMed ID: 25634555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.
    Olivotto I; d'Amati G; Basso C; Van Rossum A; Patten M; Emdin M; Pinto Y; Tomberli B; Camici PG; Michels M
    Cardiovasc Res; 2015 Apr; 105(4):409-23. PubMed ID: 25631583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets for therapy in sarcomeric cardiomyopathies.
    Tardiff JC; Carrier L; Bers DM; Poggesi C; Ferrantini C; Coppini R; Maier LS; Ashrafian H; Huke S; van der Velden J
    Cardiovasc Res; 2015 Apr; 105(4):457-70. PubMed ID: 25634554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electro-mechanical conditioning of human iPSC-derived cardiomyocytes for translational research.
    Kroll K; Chabria M; Wang K; Häusermann F; Schuler F; Polonchuk L
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):212-222. PubMed ID: 28688751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
    Wyles SP; Hrstka SC; Reyes S; Terzic A; Olson TM; Nelson TJ
    Clin Transl Sci; 2016 Jun; 9(3):158-67. PubMed ID: 27105042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.
    Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ
    Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
    Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
    Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research priorities in sarcomeric cardiomyopathies.
    van der Velden J; Ho CY; Tardiff JC; Olivotto I; Knollmann BC; Carrier L
    Cardiovasc Res; 2015 Apr; 105(4):449-56. PubMed ID: 25631582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.